Ligand validation:6HJ3

LMT: DODECYL-BETA-D-MALTOSIDE

LMT is a Ligand Of Interest in 6HJ3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HJ3_LMT_A_408	4%	70%	0.382	0.889	0.74	0.42	-	-	0	0	34%	0.3429
6HJ3_LMT_C_406	3%	70%	0.392	0.87	0.75	0.41	-	-	1	0	34%	0.3429
6HJ3_LMT_D_406	3%	64%	0.427	0.871	0.82	0.56	-	-	1	0	34%	0.3429
6HJ3_LMT_B_407	2%	63%	0.422	0.849	0.99	0.44	-	-	1	0	34%	0.3429
6HJ3_LMT_E_406	1%	69%	0.516	0.85	0.71	0.48	-	-	0	0	34%	0.3429
6HJ3_LMT_D_401	0%	65%	0.697	0.873	0.74	0.61	-	-	1	0	34%	0.3429
5IUX_LMT_E_402	53%	27%	0.131	0.89	1.53	1.39	7	7	0	0	100%	1
3EAM_LMT_C_502	52%	15%	0.14	0.898	1.32	2.41	4	18	0	6	100%	1
6HYV_LMT_C_402	35%	69%	0.197	0.886	0.25	0.91	-	3	1	0	100%	1
3TLU_LMT_C_318	27%	49%	0.17	0.933	0.75	1.22	-	2	1	0	34%	0.3429
3TLW_LMT_C_318	22%	55%	0.177	0.914	0.36	1.34	-	1	0	0	34%	0.3429
5NV9_LMT_A_504	99%	31%	0.045	0.983	0.57	2.12	-	12	1	0	100%	1
7M78_LMT_L_202	95%	44%	0.073	0.976	1.13	1.04	3	2	0	0	100%	1
3CAY_LMT_A_512	94%	59%	0.071	0.968	0.66	0.9	-	1	0	0	100%	1
4U8Y_LMT_C_1101	83%	64%	0.096	0.953	0.43	0.92	-	1	2	0	100%	1
3T2K_LMT_A_501	82%	32%	0.082	0.936	1.31	1.4	4	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.